XWPharma - Crunchbase Company Profile & Funding

Q: Who invested in XWPharma?

XWPharma has 8 investors including Panacea Venture And CDIB Capital Group.

Q: When was the last funding round for XWPharma?

XWPharma closed its last funding round on obfuscated from a Series C round.

Q: How much funding has XWPharma raised to date?

XWPharma has raised obfuscated.

Overview

XWPharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About XWPharma

CB Rank

66191

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

Founded

obfuscation

Private

Series C

Redwood City, California, United States

11-50

www.xwpharma.com/

Biopharma

Biotechnology

Neuroscience

Funding Rounds

Series C

OBF

obfuscation

Key People

Asish Xavier: Member Board of Directors
Past Role: Johnson & Johnson, Senior Associate - Venture Investments
William Xiang: Head of Strategy, Program Management & Operations

Details

Legal Name

XWPharma Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses. Bay Area, CA US.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Valiloxybate

An investigational GABA B agonist developed for treating sleep disorders in narcolepsy and Parkinson’s disease patients.

XW10508

An investigational oral glutamatergic agent targeting NMDA receptor inhibition and AMPA receptor activation for major depressive disorder and chronic pain.

Research & Development

XWPharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C
obfuscated obfuscation	Series C - XWPharma	8	obfuscated obfuscation	Panacea Venture	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Panacea Venture	Yes	Series C - XWPharma	James Huang
Panacea Venture	Yes	Series C - XWPharma	James Huang
Panacea Venture	Yes	Series C - XWPharma	James Huang
Panacea Venture	Yes	Series C - XWPharma	James Huang
Panacea Venture	Yes	Series C - XWPharma	James Huang